Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2009
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality
Kathryn L Penney, Claudia A Salinas, Mark Pomerantz, et al.
Journal of the National Cancer Institute
|
March 26, 2009
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer
Toshiro Migita, Stacey Ruiz, Alessandro Fornari, et al.
Trials
|
October 6, 2017
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial
Gráinne Sheill, Lauren Brady, Emer Guinan, et al.
JAMA Network Open
|
February 17, 2026
Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors
Erika Rees-Punia, Lauren R Teras, Christina C Newton, et al.
Plos One
|
December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial
Lauren Brady, Brian Hayes, Gráinne Sheill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 22, 2023
ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer
Gráinne Sheill, Lauren Brady, Brian Hayes, et al.
BMJ Open
|
May 17, 2018
Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol
Robert U Newton, Stacey A Kenfield, Nicolas H Hart, et al.
The Prostate
|
May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer
Victoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Nature
|
February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 16, 2009
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality
Kathryn L Penney, Claudia A Salinas, Mark Pomerantz, et al.
Journal of the National Cancer Institute
|
March 26, 2009
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer
Toshiro Migita, Stacey Ruiz, Alessandro Fornari, et al.
Trials
|
October 6, 2017
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial
Gráinne Sheill, Lauren Brady, Emer Guinan, et al.
JAMA Network Open
|
February 17, 2026
Leisure-Time Physical Activity and Cancer Mortality Among Cancer Survivors
Erika Rees-Punia, Lauren R Teras, Christina C Newton, et al.
Plos One
|
December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial
Lauren Brady, Brian Hayes, Gráinne Sheill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 22, 2023
ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer
Gráinne Sheill, Lauren Brady, Brian Hayes, et al.
BMJ Open
|
May 17, 2018
Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol
Robert U Newton, Stacey A Kenfield, Nicolas H Hart, et al.
The Prostate
|
May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer
Victoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Nature
|
February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
Page
of 8